Advanced Medical Solutions Group plc
AMS.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £1 | £1 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 1.1% | 61.1% | 7.7% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 53.5% | 44.9% | 54.3% | 54.6% |
| EBITDA | £0 | £0 | £0 | £0 |
| % Margin | 17.9% | 16.4% | 13% | 24.8% |
| Net Income | £0 | £0 | £0 | £0 |
| % Margin | 5.6% | 2.7% | 6.1% | 11% |
| EPS Diluted | 0.028 | 0.013 | 0.019 | 0.032 |
| % Growth | 113.5% | -30.7% | -39.8% | – |
| Operating Cash Flow | £0 | £0 | £0 | £0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | £0 | £0 | £0 | £0 |